• Scroll to top
    • Follow Us
    • –
    • Fb.
    • Tw.
    • Li.
    • Yt.
    • Inst.
Skip to content
CLINUVEL
CLINUVEL
CLINUVEL
CLINUVEL
CLINUVEL CLINUVEL
  • About
    • Company
      • About CLINUVEL
        • Risk Management & ESG Statement
      • Mission, Vision & Values
      • History & Future
    • People
      • Board
      • Management
      • Corporate Governance
  • Pharmaceutical Technology
    • SCENESSE®
    • About Melanocortins
    • Published Research
    • Scientific Communiqués
    • Pipeline
  • Disease Entities
    • Erythropoietic Protoporphyria (EPP)
    • Variegate Porphyria (VP)
    • Vitiligo
    • DNA Repair
    • Xeroderma Pigmentosum (XP)
    • Arterial Ischaemic Stroke (AIS)
  • Healthcare Solutions
  • Investors
    • News
      • Latest News
      • Share Price
      • Announcements Calendar
      • CLINUVEL Online
    • ASX Announcements
    • Company Snapshot
    • Financial Overview
    • Shareholder Information
    • Media Coverage
    • Analyst Coverage
    • Annual Reports
    • Enquiries
    • FAQ
© CLINUVEL PHARMACEUTICALS LTD 2023. All rights reserved. | Sitemap | Disclaimer | Privacy Policy
To report suspected adverse reactions, contact CLINUVEL via safety@clinuvel.com or (US only) the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
  • Follow Us
  • –
  • Fb.
  • Tw.
  • Li.
  • Yt.
  • Inst.
  • Contact Us
Back
2020 Announcements Presentation

jefferies

Tag
  1. Home
  2. Tag: jefferies
Showing 1-1 of 1 results
Filter
CLINUVEL
Posted by CLINUVEL
June 5, 2020
2020 Announcements Presentation
1 min read

Presentation Jefferies Global Healthcare Conference

Download PDF

Read More
  • CLINUVEL
  • Per diligentiam sinceritatemque progredimur et populum servimus

  • Offices

    • Australia
    • Singapore
    • United States
    • Ireland
    • United Kingdom
    • Switzerland
  • Phone

    • Tel: +61 3 9660 4900
    • Fax: +61 3 9660 4909
  • Healthcare Professional?

    Click Here
  • Stay in touch

    Join our mailing list

    Read our privacy policy to understand how we handle your data

© CLINUVEL PHARMACEUTICALS LTD 2023. All rights reserved. | Sitemap | Disclaimer | Privacy Policy
To report suspected adverse reactions, contact CLINUVEL via safety@clinuvel.com or (US only) the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.